The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
, absorption correction [4] positions with the help of the SHELX program (AFIX 43, 23 or 137 option) [1] with U iso (H) = k times Ueq(N,C), where k = 1.5 for CH 3 H atoms and 1.2 for other H atoms.
Comment
The title compound is a very important intermediate in the production of Omarigliptin. Omarigliptin (MK-3102) is an oral hypoglycemic agent of super long-lasting dipeptidyl peptidase-4 (DPP-4) developed by Merck & Co., USA. Its mechanism of action is through inhibiting the degrading of the in vivo dipeptidyl peptidase-4 (DPP-4) on the GLP-1, prolonging the action time of glucagon-like peptide-1 (GLP-1), thereby increasing the blood concentration of the endogenous GLP-1 and GIP, and ultimately improving blood glucose control [6] . The molecular structure of the title compound is shown in the figure. The bond lengths and angles are within normal ranges [7] . The crystal structure analysis of the title compound revealed that the two rings A (C1-C2-C3-N1-N2) and B (C2-C3-C4-N3-C5) are almost planar. The dihedral angle between ring A and ring B is 1.7(2)°. In the crystal of the title compound, there are intermolecular N-H· · · O hydrogen bonds connecting adjacent molecules to chains. According to the N· · · O distance of 2.791(2) Å, this hydrogen bond is to be classified as medium strong. Technology (JIT-B-201323, JIT-B-201601 and JIT-B-201211).
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